Patent_application_number,Applicant_name,Year_of_application,Patent_system
US6673600B2,SANOFI,2004,USPTO
US6673902B2,ST. JUDE CHILDRENS RESEARCH HOSPITAL,2004,USPTO
US6673910B1,THERMO FISHER SCIENTIFIC,2004,USPTO
US6677500B2,UNIVERSITY OF ILLINOIS,2004,USPTO
US6682905B1,NEW YORK UNIVERSITY,2004,USPTO
US6682917B1,TAKEDA CHEMICAL INDUSTRIES LTD,2004,USPTO
US6682921B1,NEW YORK UNIVERSITY,2004,USPTO
US6686188B2,GE HEALTHCARE,2004,USPTO
US6689581B1,PFIZER,2004,USPTO
US6689807B1,"CARITAS ST. ELIZABETH'S MEDICAL CENTER OF BOSTON, INC.; BOSTON, MA",2004,USPTO
US6689866B1,CELLDEX,2004,USPTO
US6692748B2,BRISTOL-MYERS SQUIBB COMPANY,2004,USPTO
US6692917B2,HOLOGIC INC,2004,USPTO
US6692962B1,"UNIVERSITY OF WYOMING; LARAMIE, WY",2004,USPTO
US6693172B1,DAHALER CORPORATION,2004,USPTO
US6696273B2,SANOFI,2004,USPTO
US6696547B2,DKFZ,2004,USPTO
US6703485B2,COLUMBIA UNIVERSITY,2004,USPTO
US6703487B2,AMGEN,2004,USPTO
US6706869B1,PFIZER,2004,USPTO
US6710170B2,GSK PLC,2004,USPTO
US6713065B2,HARVARD MEDICAL SCHOOL,2004,USPTO
US6713607B2,PFIZER,2004,USPTO
US6720139B1,"ELITRA PHARMACEUTICALS, INC.; SAN DIEGO, CA",2004,USPTO
US6720154B1,THE ROCKEFELLER UNIVERSITY,2004,USPTO
US6720173B1,LEXICON PHARMACEUTICALS,2004,USPTO
US6730491B2,TAKEDA CHEMICAL INDUSTRIES LTD,2004,USPTO
US6733991B1,ASTELLAS PHARMA INC ,2004,USPTO
US6734009B2,LEXICON PHARMACEUTICALS,2004,USPTO
US6737244B2,RIGEL PHARMACEUTICALS,2004,USPTO
US6737404B2,"3-DIMENSIONAL PHARMACEUTICALS, INC.; EXTON, PA",2004,USPTO
US6740737B2,TAKEDA CHEMICAL INDUSTRIES LTD,2004,USPTO
US6746861B2,LEXICON PHARMACEUTICALS,2004,USPTO
US6747137B1,THERMO FISHER SCIENTIFIC,2004,USPTO
US6750012B1,CELLDEX,2004,USPTO
US6750042B2,UNIV GEORGIA,2004,USPTO
US6750054B2,LEXICON PHARMACEUTICALS,2004,USPTO
US6752987B1,UNIVERSITY OF CALIFORNIA,2004,USPTO
US6759389B1,"GENERVON BIOPHARMACEUTICALS LLC; MONTEBELLO, CA",2004,USPTO
US6767736B2,LEXICON PHARMACEUTICALS,2004,USPTO
US6777247B2,ACADEMIA SINICA,2004,USPTO
US6777545B2,LEXICON PHARMACEUTICALS,2004,USPTO
US6783953B1,THE JOHNSON & JOHNSON,2004,USPTO
US6783954B2,COMPUGEN LTD. (IL),2004,USPTO
US6783955B2,INCYTE GENOMICS,2004,USPTO
US6783961B1,MERCK,2004,USPTO
US6783969B1,THERMO FISHER SCIENTIFIC,2004,USPTO
US6783970B2,TAKARA HOLDINGS,2004,USPTO
US6787345B1,TAKEDA CHEMICAL INDUSTRIES LTD,2004,USPTO
US6787640B2,GSK PLC,2004,USPTO
US6787644B1,AMGEN,2004,USPTO
US6790637B1,"CERYLID PTY., LTD.; RICHMOND; AUX;",2004,USPTO
US6790667B1,LEXICON PHARMACEUTICALS,2004,USPTO
US6794186B2,NOVARTIS,2004,USPTO
US6794491B1,TAKEDA CHEMICAL INDUSTRIES LTD,2004,USPTO
US6797695B1,KYOTO UNIVERSITY,2004,USPTO
US6806054B2,"ARENA PHARMACEUTICALS, INC.; SAN DIEGO, CA",2004,USPTO
US6812339B1,THERMO FISHER SCIENTIFIC,2004,USPTO
US6818222B1,NOVARTIS,2004,USPTO
US6821745B2,BAYER,2004,USPTO
US6821946B2,UCL,2004,USPTO
US6822082B2,BRISTOL-MYERS SQUIBB COMPANY,2004,USPTO
US6830898B2,"OMNIGENE BIOPRODUCTS, INC.; CAMBRIDGE, MA",2004,USPTO
US6833446B1,AGRIGENESIS BIOSCIENCES LIMITED AND RUBICON FOREST HOLDINGS LIMITED; AUCKLAND; NZX;,2004,USPTO